27.32
price up icon1.21%   0.29
after-market Dopo l'orario di chiusura: 27.32
loading
Precedente Chiudi:
$27.03
Aprire:
$26.8
Volume 24 ore:
1.07M
Relative Volume:
1.10
Capitalizzazione di mercato:
$2.18B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-36.43
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+1.78%
1M Prestazione:
+2.81%
6M Prestazione:
-30.91%
1 anno Prestazione:
+28.26%
Intervallo 1D:
Value
$26.59
$27.74
Intervallo di 1 settimana:
Value
$26.01
$27.74
Portata 52W:
Value
$19.73
$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name
Nome
Veracyte Inc
Name
Telefono
(650) 243-6300
Name
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Dipendente
824
Name
Cinguettio
@veracyte
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
VCYT's Discussions on Twitter

Confronta VCYT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
VCYT
Veracyte Inc
27.32 2.18B 399.58M -54.04M 40.13M -0.75
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.46 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.10 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.66 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.44 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.62 27.64B 15.50B 1.33B 2.16B 7.34

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-20 Iniziato Craig Hallum Buy
2024-12-05 Downgrade Goldman Buy → Neutral
2024-11-15 Iniziato Wolfe Research Outperform
2024-10-16 Iniziato UBS Buy
2024-10-10 Iniziato Guggenheim Buy
2024-02-23 Reiterato Needham Buy
2023-01-18 Downgrade Raymond James Outperform → Mkt Perform
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-01-07 Iniziato Stephens Overweight
2021-11-18 Ripresa Goldman Buy
2021-06-15 Iniziato Raymond James Outperform
2021-02-18 Ripresa Needham Buy
2021-01-28 Iniziato Truist Buy
2020-11-10 Iniziato KeyBanc Capital Markets Sector Weight
2020-09-09 Iniziato Morgan Stanley Underweight
2019-07-31 Iniziato Lake Street Buy
2019-07-02 Iniziato Needham Buy
2018-11-29 Downgrade Janney Buy → Neutral
2018-10-31 Aggiornamento Janney Neutral → Buy
2017-11-07 Downgrade Janney Buy → Neutral
2017-11-07 Downgrade Piper Jaffray Overweight → Neutral
2017-08-31 Ripresa BTIG Research Buy
2016-11-14 Ripresa Leerink Partners Outperform
2015-12-18 Iniziato Cantor Fitzgerald Buy
2015-06-11 Reiterato Leerink Partners Outperform
2013-11-26 Iniziato William Blair Outperform
Mostra tutto

Veracyte Inc Borsa (VCYT) Ultime notizie

pulisher
Jun 18, 2025

Veracyte shareholders approve 2.5 million share increase to equity plan - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Veracyte shareholders approve 2.5 million share increase to equity plan By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 17, 2025
pulisher
Jun 15, 2025

Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st

Jun 15, 2025
pulisher
Jun 09, 2025

Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey

Jun 09, 2025
pulisher
Jun 07, 2025

Cathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D Systems - Benzinga

Jun 07, 2025
pulisher
Jun 06, 2025

Insider Selling: John Leite Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 By Investing.com - Investing.com Canada

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock - Investing.com Nigeria

Jun 06, 2025
pulisher
Jun 06, 2025

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Top Companies in the NASDAQ Veracyte and Others by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Cuts Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Veracyte at Jefferies Global Healthcare Conference: Strategic Growth and Innovation - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant By Investing.com - Investing.com Nigeria

Jun 04, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Veracyte at William Blair Growth Stock Conference: Strategic Insights Unveiled - Investing.com Canada

Jun 04, 2025
pulisher
Jun 01, 2025

Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO - MSN

May 31, 2025
pulisher
May 29, 2025

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research - BioSpace

May 29, 2025
pulisher
May 29, 2025

Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 28, 2025

Veracyte (VCYT) Showcases Findings at ASCO Annual Meeting | VCYT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veracyte to present multiple abstracts at ASCO - TipRanks

May 28, 2025
pulisher
May 28, 2025

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research | VCYT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veracyte Inc (VCYT) Shares Gap Down to $26.74 on May 28 - GuruFocus

May 28, 2025
pulisher
May 26, 2025

Veracyte: Upgrading To Neutral (NASDAQ:VCYT) - Seeking Alpha

May 26, 2025
pulisher
May 23, 2025

Captrust Financial Advisors Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 23, 2025
pulisher
May 21, 2025

Scotiabank maintains Veracyte stock with $44 target - Investing.com

May 21, 2025
pulisher
May 21, 2025

Scotiabank maintains Veracyte stock with $44 target By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Deutsche Bank AG Has $3.22 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 21, 2025
pulisher
May 20, 2025

Veracyte to Participate in Upcoming Investor Conferences - 01net

May 20, 2025
pulisher
May 20, 2025

Veracyte to Participate in Upcoming Investor Conferences | VCYT Stock News - GuruFocus

May 20, 2025
pulisher
May 19, 2025

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? - Zacks Investment Research

May 19, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Sells 55,684 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 18, 2025
pulisher
May 17, 2025

William Blair Estimates Veracyte’s Q2 Earnings (NASDAQ:VCYT) - Defense World

May 17, 2025
pulisher
May 13, 2025

Stifel Financial Corp Sells 2,211 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World

May 13, 2025
pulisher
May 11, 2025

Veracyte projects strong Decipher and Afirma growth, targets 22.5% adjusted EBITDA margin for 2025 - MSN

May 11, 2025

Veracyte Inc Azioni (VCYT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Veracyte Inc Azioni (VCYT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Bhanji Muna
Director
Jun 13 '25
Sale
26.67
4,589
122,367
29,989
diagnostics_research DGX
$179.34
price down icon 0.19%
diagnostics_research WAT
$357.04
price up icon 2.29%
diagnostics_research LH
$264.25
price up icon 0.66%
$160.72
price down icon 4.77%
diagnostics_research MTD
$1,205.37
price up icon 2.54%
diagnostics_research IQV
$162.62
price up icon 3.19%
Capitalizzazione:     |  Volume (24 ore):